blend labs inc. - BLND
BLND
Close Chg Chg %
3.70 0.03 0.81%
Closed Market
3.73
+0.03 (0.81%)
Volume: 1.34M
Last Updated:
Jun 5, 2025, 3:59 PM EDT
Company Overview: blend labs inc. - BLND
BLND Key Data
| Open $3.68 | Day Range 3.68 - 3.78 |
| 52 Week Range 2.08 - 5.52 | Market Cap $956.54M |
| Shares Outstanding 258.52M | Public Float 203.63M |
| Beta 1.31 | Rev. Per Employee N/A |
| P/E Ratio N/A | EPS -$0.21 |
| Yield 0.00% | Dividend N/A |
| EX-DIVIDEND DATE | SHORT INTEREST N/A |
| AVERAGE VOLUME 2.50M |
BLND Performance
| 1 Week | 1.09% | ||
| 1 Month | 11.78% | ||
| 3 Months | 19.35% | ||
| 1 Year | 39.10% | ||
| 5 Years | N/A |
BLND Analyst Ratings
- Sell
- Under
- Hold
- Over
- Buy
Number of Ratings
7
Full Ratings ➔
About blend labs inc. - BLND
Blend Labs, Inc. engages in the provision of a cloud-based software platform for financial services firms that is designed to power the end-to-end consumer journey for banking products. It operates through the Blend Platform and Title365 segments. The company was founded by Nima Ghamsari, Rosco Hill, Eugene Marinelli, and Erin James Collard on April 17, 2012 and is headquartered in Novato, CA.
BLND At a Glance
Blend Labs, Inc.
7250 Redwood Boulevard
Novato, California 94945
| Phone | 1-650-550-4810 | Revenue | 162.02M | |
| Industry | Information Technology Services | Net Income | -60,483,000.00 | |
| Sector | Technology Services | 2024 Sales Growth | 3.298% | |
| Fiscal Year-end | 12 / 2025 | Employees | 540 | |
| View SEC Filings |
BLND Valuation
| P/E Current | N/A |
| P/E Ratio (with extraordinary items) | N/A |
| P/E Ratio (without extraordinary items) | N/A |
| Price to Sales Ratio | 6.598 |
| Price to Book Ratio | N/A |
| Price to Cash Flow Ratio | N/A |
| Enterprise Value to EBITDA | -32.083 |
| Enterprise Value to Sales | 7.181 |
| Total Debt to Enterprise Value | 0.125 |
BLND Efficiency
| Revenue/Employee | 300,035.185 |
| Income Per Employee | -112,005.556 |
| Receivables Turnover | 8.14 |
| Total Asset Turnover | 0.844 |
BLND Liquidity
| Current Ratio | 3.438 |
| Quick Ratio | 3.438 |
| Cash Ratio | 2.657 |
BLND Profitability
| Gross Margin | 55.226 |
| Operating Margin | -26.015 |
| Pretax Margin | -26.731 |
| Net Margin | -37.331 |
| Return on Assets | -31.495 |
| Return on Equity | N/A |
| Return on Total Capital | -67.852 |
| Return on Invested Capital | -57.011 |
BLND Capital Structure
| Total Debt to Total Equity | N/A |
| Total Debt to Total Capital | 163.223 |
| Total Debt to Total Assets | 81.733 |
| Long-Term Debt to Equity | N/A |
| Long-Term Debt to Total Capital | 159.822 |
- Income Statement
- Balance Sheet
- Cash Flow Statement
Annual Financials for Blend Labs Inc. - BLND
Collapse All in section
| All values USD millions. | 2021 | 2022 | 2023 | 2024 | 5-year trend |
|---|---|---|---|---|---|
Sales/Revenue
| 234.50M | 235.20M | 156.85M | 162.02M | |
Sales Growth
| +144.19% | +0.30% | -33.31% | +3.30% | |
Cost of Goods Sold (COGS) incl D&A
| 126.64M | 153.96M | 75.71M | 72.54M | |
COGS excluding D&A
| - | - | - | - | - |
Depreciation & Amortization Expense
| 13.81M | 14.42M | 5.76M | 5.89M | |
Depreciation
| 4.61M | 5.95M | 5.70M | 4.33M | |
Amortization of Intangibles
| 9.21M | 8.47M | 64.00K | 489.00K | |
COGS Growth
| +269.34% | +21.57% | -50.82% | -4.18% | |
Gross Income
| 107.85M | 81.24M | 81.14M | 89.48M | |
Gross Income Growth
| +74.69% | -24.68% | -0.13% | +10.28% | |
Gross Profit Margin
| +45.99% | +34.54% | +51.73% | +55.23% |
| 2021 | 2022 | 2023 | 2024 | 5-year trend | |
|---|---|---|---|---|---|
SG&A Expense
| 296.60M | 362.46M | 212.41M | 131.63M | |
Research & Development
| 92.22M | 138.09M | 81.59M | 46.09M | |
Other SG&A
| 204.38M | 224.37M | 130.82M | 85.54M | |
SGA Growth
| +116.44% | +22.21% | -41.40% | -38.03% | |
Other Operating Expense
| - | - | - | - | - |
Unusual Expense
| 8.50M | 464.95M | 24.95M | 3.73M | |
EBIT after Unusual Expense
| (197.24M) | (746.18M) | (156.22M) | (45.88M) | |
Non Operating Income/Expense
| 493.00K | 4.92M | 7.25M | 9.32M | |
Non-Operating Interest Income
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Interest Expense
| 11.28M | 24.79M | 30.81M | 6.75M | |
Interest Expense Growth
| - | +119.79% | +24.29% | -78.10% | |
Gross Interest Expense
| 11.28M | 24.79M | 30.81M | 6.75M | |
Interest Capitalized
| - | - | - | - | - |
Pretax Income
| (208.03M) | (766.05M) | (179.78M) | (43.31M) | |
Pretax Income Growth
| -178.89% | -268.24% | +76.53% | +75.91% | |
Pretax Margin
| -88.71% | -325.70% | -114.63% | -26.73% | |
Income Tax
| (38.89M) | (2.24M) | 94.00K | 109.00K | |
Income Tax - Current - Domestic
| 425.00K | 355.00K | 41.00K | 64.00K | |
Income Tax - Current - Foreign
| - | 268.00K | 87.00K | 11.00K | |
Income Tax - Deferred - Domestic
| - | - | (39.31M) | (2.86M) | - |
Income Tax - Deferred - Foreign
| - | - | (34.00K) | 34.00K | - |
Income Tax Credits
| - | - | - | - | - |
Equity in Earnings of Affiliates
| - | - | - | - | - |
Other After Tax Income (Expense)
| (1.43M) | (48.44M) | (6.63M) | (17.14M) | |
Consolidated Net Income
| (170.57M) | (812.25M) | (186.51M) | (60.56M) | |
Minority Interest Expense
| 771.00K | (43.64M) | (1.19M) | (74.00K) | |
Net Income
| (171.34M) | (768.61M) | (185.32M) | (60.48M) | |
Net Income Growth
| -129.63% | -348.58% | +75.89% | +67.36% | |
Net Margin Growth
| -73.07% | -326.79% | -118.15% | -37.33% | |
Extraordinaries & Discontinued Operations
| - | - | - | - | - |
Discontinued Operations
| - | - | - | - | - |
Net Income After Extraordinaries
| (171.34M) | (768.61M) | (185.32M) | (60.48M) | |
Preferred Dividends
| - | - | - | - | - |
Net Income Available to Common
| (171.34M) | (768.61M) | (185.32M) | (60.48M) | |
EPS (Basic)
| -0.7439 | -3.2824 | -0.7558 | -0.2382 | |
EPS (Basic) Growth
| -118.92% | -341.24% | +76.97% | +68.48% | |
Basic Shares Outstanding
| 230.32M | 234.16M | 245.21M | 253.92M | |
EPS (Diluted)
| -0.7439 | -3.2824 | -0.7558 | -0.2382 | |
EPS (Diluted) Growth
| -118.92% | -341.24% | +76.97% | +68.48% | |
Diluted Shares Outstanding
| 230.32M | 234.16M | 245.21M | 253.92M | |
EBITDA
| (174.93M) | (266.81M) | (125.51M) | (36.26M) | |
EBITDA Growth
| -153.72% | -52.52% | +52.96% | +71.11% | |
EBITDA Margin
| -74.60% | -113.44% | -80.02% | -22.38% |
Snapshot
| Average Recommendation | OVERWEIGHT | Average Target Price | 4.925 | |
| Number of Ratings | 7 | Current Quarters Estimate | 0.019 | |
| FY Report Date | 06 / 2025 | Current Year's Estimate | 0.05 | |
| Last Quarter’s Earnings | -0.01 | Median PE on CY Estimate | N/A | |
| Year Ago Earnings | -0.12 | Next Fiscal Year Estimate | 0.115 | |
| Median PE on Next FY Estimate | N/A |
Earnings Per Share
| This Quarter | Next Quarter | This Fiscal | Next Fiscal | |
|---|---|---|---|---|
| # of Estimates | 5 | 5 | 5 | 6 |
| Mean Estimate | 0.02 | 0.02 | 0.05 | 0.12 |
| High Estimates | 0.02 | 0.02 | 0.07 | 0.16 |
| Low Estimate | 0.02 | 0.01 | 0.03 | 0.05 |
| Coefficient of Variance | 8.09 | 27.14 | 28.30 | 37.44 |
Analysts Recommendations
| Current | 1 Month Ago | 3 Months Ago | |
|---|---|---|---|
| BUY | 5 | 5 | 5 |
| OVERWEIGHT | 0 | 0 | 0 |
| HOLD | 2 | 2 | 2 |
| UNDERWEIGHT | 0 | 0 | 0 |
| SELL | 0 | 0 | 0 |
| MEAN | Overweight | Overweight | Overweight |
SEC Filings for Blend Labs Inc. - BLND
| Filing Date | Type | Category | Amended |
|---|---|---|---|
| No results | |||
Insider Actions for Blend Labs Inc. - BLND
| Date | Name | Shares | Transaction | Value |
|---|---|---|---|---|
| Mar 17, 2025 | Nima Ghamsari HEAD OF BLEND; Director | 1,000,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Nima Ghamsari HEAD OF BLEND; Director | 4,200,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Winnie Ling HEAD OF LEGAL AND PEOPLE | 250,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Oxana Tkach PRINCIPAL ACCOUNTING OFFICER | 250,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Oxana Tkach PRINCIPAL ACCOUNTING OFFICER | 100,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Amir Jafari HEAD OF FINANCE AND ADMIN. | N/A | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 17, 2025 | Amir Jafari HEAD OF FINANCE AND ADMIN. | N/A | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 17, 2025 | Amir Jafari HEAD OF FINANCE AND ADMIN. | 1,300,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Amir Jafari HEAD OF FINANCE AND ADMIN. | 750,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Winnie Ling HEAD OF LEGAL AND PEOPLE | 800,000 | Grant, award or other acq pursuant to Rule 16b-3(d) | 0.00 |
| Mar 17, 2025 | Winnie Ling HEAD OF LEGAL AND PEOPLE | N/A | Disposition to the issuer of issuer equity secs pursant to Rule 16b-3 | 0.00 |
| Mar 12, 2025 | Haveli Investments LP Director | 2,060,925 | Open market or private purchase of non-derivative security Non-derivative transaction at $3.05 per share | 6,285,821.25 |
| Feb 24, 2025 | Winnie Ling HEAD OF LEGAL AND PEOPLE | 100,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Oxana Tkach PRINCIPAL ACCOUNTING OFFICER | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Winnie Ling HEAD OF LEGAL AND PEOPLE | N/A | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Winnie Ling HEAD OF LEGAL AND PEOPLE | 340,059 | Open market or private sale of non-derivative or derivative security Non-derivative transaction at $3.91 per share | 1,329,630.69 |
| Feb 24, 2025 | Amir Jafari HEAD OF FINANCE AND ADMIN. | 75,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Oxana Tkach PRINCIPAL ACCOUNTING OFFICER | 101,429 | Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $3.99 per share | 404,701.71 |
| Feb 24, 2025 | Nima Ghamsari HEAD OF BLEND; Director | 3,750,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |
| Feb 24, 2025 | Oxana Tkach PRINCIPAL ACCOUNTING OFFICER | 250,000 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 0.00 |